Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

AJCC Cancer Staging Manual

(2016) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,300

A System for the Surgical Staging of Musculoskeletal Sarcoma

Enneking, W. F., Spanier, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,661

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Casali, P. G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I. P., Bovée, J. V. M. G., Brodowicz, T., Broto, J. M., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy096 · Cited by 1,615

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

Gronchi, A., Miah, A. B., Dei Tos, A. P., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., Bolle, S., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.07.006 · Cited by 1,115

Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group

Cotterill, S. J., Ahrens, S., Paulussen, M., Jürgens, H., Voûte, P. A., Gadner, H., & Craft, A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3108 · Cited by 1,035

IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

Amary, M. F., Bacsi, K., Maggiani, F., Damato, S., Halai, D., Berisha, F., Pollock, R., O'Donnell, P., Grigoriadis, A., Diss, T., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2913 · Cited by 1,023

Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone

Behjati, S., Tarpey, P. S., Presneau, N., Scheipl, S., Pillay, N., Van Loo, P., Wedge, D. C., Cooke, S. L., Gundem, G., Davies, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2814 · Cited by 854

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

Womer, R. B., West, D. C., Krailo, M., Dickman, P. S., Pawel, B., Grier, H. E., Marcus, K. J., Sailer, S. L., Healey, J. H., Dormans, J. P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5703 · Cited by 761

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.14.0095 · Cited by 752

Osteosarcoma

Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660

Current advance of nanotechnology in diagnosis and treatment for malignant tumors

Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 641

Anthracycline Cardiotoxicity in Adult Cancer Patients

Camilli, M., Cipolla, C. M., Dent, S. F., Minotti, G., & Cardinale, D. M. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.07.016 · Cited by 250

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline

Tung, N., Ricker, C. N., Messersmith, H. J., Balmañà, J., Domchek, S. M., Stoffel, E. M., Almhanna, K., Arun, B., Chávarri-Guerra, Y., Cohen, S. A., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.24.00662 · Cited by 143

Osteosarcoma: Current Concepts and Evolutions in Management Principles

Pilavaki, P., Ardakani, A. H. G., Gikas, P. D., & Constantinidou, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082785 · Cited by 70

UK guidelines for the management of bone sarcomas

Gerrand, C., Amary, F. M., Anwar, H. A., Brennan, B. M. D., Dileo, P., Kalkat, M. S., McCabe, M. G., McCullough, A. L., Parry, M., Patel, A., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02868-4 · Cited by 69

Automated prediction of the neoadjuvant chemotherapy response in osteosarcoma with deep learning and an MRI-based radiomics nomogram

Zhong, J., Zhang, C., Hu, Y., Zhang, J., Liu, Y., Si, L., Xing, Y., Ding, D., Geng, J., Jiao, Q., et al. (2022) · European Radiology · doi:10.1007/s00330-022-08735-1 · Cited by 58

Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness

Panagi, M., Pilavaki, P., Constantinidou, A., & Stylianopoulos, T. (2022) · Theranostics · doi:10.7150/thno.72800 · Cited by 59

Improved nationwide survival of sarcoma patients with a network of reference centers

Blay, J., Penel, N., Valentin, T., Anract, P., Duffaud, F., Dufresne, A., Verret, B., Córdoba, A., Italiano, A., Brahmi, M., et al. (2024) · Annals of Oncology · doi:10.1016/j.annonc.2024.01.001 · Cited by 54

Small round cell sarcomas

Cidre‐Aranaz, F., Watson, S., Amatruda, J. F., Nakamura, T., Delattre, O., de Álava, E., Dirksen, U., & Grünewald, T. G. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00393-3 · Cited by 51

Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions

Gilbert, A., Tudor, M., Montanari, J., Commenchail, K., Savu, D., Lesueur, P., & Chevalier, F. (2023) · Cancers · doi:10.3390/cancers15071962 · Cited by 51

CT and MRI radiomics of bone and soft-tissue sarcomas: an updated systematic review of reproducibility and validation strategies

Gitto, S., Cuocolo, R., Huisman, M., Messina, C., Albano, D., Omoumi, P., Kotter, E., Maas, M. M., van Ooijen, P. M. A., & Sconfienza, L. M. (2024) · Insights into Imaging · doi:10.1186/s13244-024-01614-x · Cited by 47

68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy

Lanzafame, H., Mavroeidi, I. A., Pabst, K. M., Desaulniers, M., Ingenwerth, M., Hirmas, N., Kessler, L., Nader, M. A., Bartel, T., Leyser, S., et al. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.267248 · Cited by 47

Ewing sarcoma from molecular biology to the clinic

Dupuy, M., Lamoureux, F., Mullard, M., Postec, A., Regnier, L., Baud’huin, M., Georges, S., Royer, B. B.-L., Ory, B., Rédiní, F., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1248753 · Cited by 44

Phytocompounds and Nanoformulations for Anticancer Therapy: A Review

Bozzuto, G., Calcabrini, A., Colone, M., Condello, M., Dupuis, M. L., Pellegrini, E., & Stringaro, A. (2024) · Molecules · doi:10.3390/molecules29163784 · Cited by 42

Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma

Fleuren, E. D. G., Vlenterie, M., & van der Graaf, W. T. A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1013359 · Cited by 41

Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis

Nirala, B. K., Yamamichi, T., & Yustein, J. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411367 · Cited by 42

Multimodal Imaging of Osteosarcoma: From First Diagnosis to Radiomics

Cè, M., Cellina, M. I., Ueanukul, T., Carrafiello, G., Manatrakul, R., Tangkittithaworn, P., Jaovisidha, S., Fuangfa, P., & RESNICK, D. (2025) · Cancers · doi:10.3390/cancers17040599 · Cited by 41

An updated systematic review of radiomics in osteosarcoma: utilizing CLAIM to adapt the increasing trend of deep learning application in radiomics

Zhong, J., Hu, Y., Zhang, G., Xing, Y., Ding, D., Ge, X., Pan, Z., Yang, Q., Yin, Q., Zhang, H., et al. (2022) · Insights into Imaging · doi:10.1186/s13244-022-01277-6 · Cited by 36

Radiotherapy in bone sarcoma: the quest for better treatment option

Locquet, M.-A., Brahmi, M., Blay, J., & Dutour, A. (2023) · BMC Cancer · doi:10.1186/s12885-023-11232-3 · Cited by 38

Phase 2 study for nonmetastatic extremity high‐grade osteosarcoma in pediatric and adolescent and young adult patients with a risk‐adapted strategy based on ABCB1/P‐glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS‐2)

Palmerini, E., Meazza, C., Tamburini, A., Bisogno, G., Ferraresi, V., Asaftei, S. D., Milano, G. M., Coccoli, L., Manzitti, C., Luksch, R., et al. (2022) · Cancer · doi:10.1002/cncr.34131 · Cited by 35

Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications

Ye, H., Hu, X., Wen, Y., Tu, C., Hornicek, F. J., Duan, Z., & Min, L. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01609-0 · Cited by 35

The emerging role of cancer nanotechnology in the panorama of sarcoma

Mercatali, L., Vanni, S., Miserocchi, G., Liverani, C., Spadazzi, C., Cocchi, C., Calabrese, C., Gurrieri, L., Fausti, V., Riva, N., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.953555 · Cited by 35

X-rays radiomics-based machine learning classification of atypical cartilaginous tumour and high-grade chondrosarcoma of long bones

Gitto, S., Annovazzi, A., Nulle, K., Interlenghi, M., Salvatore, C., Anelli, V., Baldi, J., Messina, C., Albano, D., Luca, F. D., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105018 · Cited by 32

Single-cell RNA-seq reveals T cell exhaustion and immune response landscape in osteosarcoma

Fan, Q., Wang, Y., Cheng, J., Pan, B., Zang, X., Liu, R., & Deng, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1362970 · Cited by 34

Imaging of Osteosarcoma: Presenting Findings, Metastatic Patterns, and Features Related to Prognosis

Crombé, A., Simonetti, M., Longhi, A., Hauger, O., Fadli, D., & Spinnato, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195710 · Cited by 32

Sarcoma care in the era of precision medicine

Wallander, K., Öfverholm, I., Boye, K., Tsagkozis, P., Papakonstantinou, A., Lin, Y., & Haglund de Flon, F. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13717 · Cited by 30

European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma

van Ewijk, R., Herold, N., Baecklund, F., Baumhoer, D., Boye, K., Gaspar, N., Harrabi, S., Haveman, L., Hecker‐Nolting, S., Hiemcke‐Jiwa, L. S., et al. (2023) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2023.100029 · Cited by 33

Targeting metastasis in paediatric bone sarcomas

Bull, E. C., Singh, A., Harden, A. M., Soanes, K., Habash, H., Toracchio, L., Carrabotta, M., Schreck, C., Shah, K. M., Riestra, P. V., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02365-z · Cited by 31

Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN

Blay, J., Casali, P. G., Ray-Coquard, I. L., Seckl, M. J., Gietema, J. A., de Herder, W. W., Caplin, M. E., Klümpen, H., Gléhen, O., Wyrwicz, L. S., et al. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.100861 · Cited by 29

Artificial intelligence large language model ChatGPT: is it a trustworthy and reliable source of information for sarcoma patients?

Valentini, M., Szkandera, J., Smolle, M. A., Scheipl, S., Leithner, A., & Andreou, D. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1303319 · Cited by 29

3D vs. 2D MRI radiomics in skeletal Ewing sarcoma: Feature reproducibility and preliminary machine learning analysis on neoadjuvant chemotherapy response prediction

Gitto, S., Corino, V., Annovazzi, A., Machado, E. M., Bologna, M., Marzorati, L., Albano, D., Messina, C., Serpi, F., Anelli, V., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1016123 · Cited by 29

Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma

Hinton, K., Kirk, A., Paul, P., & Persad, S. (2023) · Biomolecules · doi:10.3390/biom13020398 · Cited by 28

Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years

Blay, J., Piperno-Neumann, S., Watson, S., Dufresne, A., Valentin, T., Duffaud, F., Toulmonde, M., Italiano, A., Bertucci, F., Tlemsani, C., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113262 · Cited by 26

Clinical Characteristics, Prognostic Factor and a Novel Dynamic Prediction Model for Overall Survival of Elderly Patients With Chondrosarcoma: A Population-Based Study

Tong, Y., Cui, Y., Jiang, L., Pi, Y., Gong, Y., & Zhao, D. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.901680 · Cited by 25

Regulation of EWSR1-FLI1 Function by Post-Transcriptional and Post-Translational Modifications

Yu, L., Davis, I. J., & Liu, P. (2023) · Cancers · doi:10.3390/cancers15020382 · Cited by 24

YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD522

Green, D., Singh, A., Tippett, V. L., Tattersall, L., Shah, K. M., Siachisumo, C., Ward, N. J., Thomas, P., Carter, S., Jeys, L. M., et al. (2023) · Journal of bone oncology · doi:10.1016/j.jbo.2023.100474 · Cited by 24

Systematic review of craniofacial osteosarcoma regarding different clinical, therapeutic and prognostic parameters

Weber, V., Stigler, R. G., Lutz, R., Kesting, M. R., & Weber, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1006622 · Cited by 24

The immune subtypes and landscape of sarcomas

Weng, W., Yu, L., Li, Z., Tan, C., Lv, J., Lao, I. W., Hu, W., Deng, Z., Liu, Z., Wang, J., et al. (2022) · BMC Immunology · doi:10.1186/s12865-022-00522-3 · Cited by 24

Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas

Pearson, A. D., Gaspar, N., Janeway, K., Campbell-Hewson, Q., Lawlor, E. R., Copland, C., Karres, D., Norga, K., Benzaghou, F., Weiner, S., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.06.008 · Cited by 22

Surgery at specialised sarcoma centres improves patient outcomes – A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party

Hong, A., Sundaram, A., Perianayagam, G., Lo, H., Lawless, A. K., Zhou, D. D.-X., McDonough, J., Thompson, S. R., Maclean, F. M., Connolly, E. A., et al. (2023) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2023.06.003 · Cited by 22

Conventional radiography for the assessment of focal bone lesions of the appendicular skeleton: fundamental concepts in the modern imaging era

Matcuk, G. R., Waldman, L. E., Fields, B. K. K., Colangeli, M., Palmas, M., Righi, A., Filonzi, G., Crombé, A., & Spinnato, P. (2024) · Skeletal Radiology · doi:10.1007/s00256-024-04854-6 · Cited by 21

Patterns of care and outcome of CIC‐rearranged sarcoma patients: A nationwide study of the French sarcoma group

Brahmi, M., Gaspar, N., Gantzer, J., Toulmonde, M., Boudou, P., Bompas, E., Firmin, N., Valentin, T., Cancel, M., Duffaud, F., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5539 · Cited by 21

Telemedicine in Care of Sarcoma Patients beyond the COVID-19 Pandemic: Challenges and Opportunities

Tsagkaris, C., Trygonis, N., Spyrou, V., & Koulouris, A. (2023) · Cancers · doi:10.3390/cancers15143700 · Cited by 22

Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment

Serrano, C., Bauer, S., Blay, J., Casali, P. G., Cicala, C. M., Tos, A. P. D., Digklia, A., Gelderblom, H. A. J., Italiano, A., Jones, R. L., et al. (2025) · JAMA Oncology · doi:10.1001/jamaoncol.2025.3608 · Cited by 22

Biology-guided precision medicine in rare cancers: Lessons from sarcomas and neuroendocrine tumours

van der Graaf, W. T. A., Tesselaar, M. E. T., McVeigh, T. P., Oyen, W. J. G., & Fröhling, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.011 · Cited by 20

Integrating Radiogenomics and Machine Learning in Musculoskeletal Oncology Care

Kumar, R. R., Sporn, K., Khanna, A., Paladugu, P., Gowda, C., Ngo, A., Jagadeesan, R., Zaman, N., & Tavakkoli, A. (2025) · Diagnostics · doi:10.3390/diagnostics15111377 · Cited by 21

Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic Arsenal

Lopes-Brás, R., Lopéz‐Presa, D., Esperança‐Martins, M., Melo-Alvim, C., Gallego-Paez, L. M., Costa, L., & Fernandes, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214227 · Cited by 19

Indirect bilirubin impairs invasion of osteosarcoma cells via inhibiting the PI3K/AKT/MMP-2 signaling pathway by suppressing intracellular ROS

Yuan, X., Ma, C., Li, J., Li, J., Yu, R., Cai, F., Qu, G., Yu, B., Liu, L., Zeng, D., et al. (2023) · Journal of bone oncology · doi:10.1016/j.jbo.2023.100472 · Cited by 19

Risk factors for acute kidney injury after high-dose methotrexate therapy: a single-center study and narrative review

Liang, C.-A., Su, Y., Lin, S., & Tsai, T.-H. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03491-7 · Cited by 19

Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model

Kalisvaart, G. M., Berghe, T. V. D., Grootjans, W., Lejoly, M., Huysse, W. C. J., Bovée, J. V. M. G., Creytens, D., Gelderblom, H. A. J., Speetjens, F. M., Lapeire, L., et al. (2023) · Skeletal Radiology · doi:10.1007/s00256-023-04402-8 · Cited by 19

A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?

van Ewijk, R., Cleirec, M., Herold, N., le Deley, M.-C., van Eijkelenburg, N., Boudou-Rouquette, P., Risbourg, S., Strauss, S. J., Palmerini, E., Boye, K., et al. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102625 · Cited by 19

First-line Anti-GD2 Therapy Combined With Consolidation Chemotherapy in 3 Patients With Newly Diagnosed Metastatic Ewing Sarcoma or Ewing-like Sarcoma

Spasov, N., Dombrowski, F., Lode, H. N., Spasova, M., Ivanova, L. R., Mumdjiev, I., Burnusuzov, H. A., & Siebert, N. (2022) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002488 · Cited by 19

Centralized and Interdisciplinary Therapy Management in the Treatment of Sarcomas

Strönisch, A., Märdian, S., & Flörcken, A. (2023) · Life · doi:10.3390/life13040979 · Cited by 18

Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study

Cesne, A. L., Chevreau, C., Perrin, C., Italiano, A., Hervieu, A., Blay, J., Piperno-Neumann, S., Saâda-Bouzid, E., Bertucci, F., Firmin, N., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101569 · Cited by 18

Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement

Green, D., van Ewijk, R., Tirtei, E., Andreou, D., Baecklund, F., Baumhoer, D., Bielack, S., Botchu, R., Boye, K., Brennan, B. M. D., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-0101 · Cited by 20

Three-Dimension-Printed Custom-Made Prosthetic Reconstructions in Bone Tumors: A Single Center Experience

Vitiello, R., Matrangolo, M. R., Motassime, A. E., Perna, A., Cianni, L., Maccauro, G., & Ziranu, A. (2022) · Current Oncology · doi:10.3390/curroncol29070361 · Cited by 17

Exploring the landscape of immunotherapy approaches in sarcomas

Pilavaki, P., Panagi, M., Arifi, S., Jones, R. L., Stylianopoulos, T., & Constantinidou, A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1069963 · Cited by 17

CIC-DUX4 sarcomas

Brahmi, M., Vanacker, H., Macagno, N., Tirode, F., & Dufresne, A. (2022) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000855 · Cited by 16

Outcomes and Complications of Pelvic Chondrosarcomas Treated Using Navigation Guidance and Multidisciplinary Approach: Is the Tumor Volume a Prognostic Factor?

Crimì, A., Binitie, O. T., Crimì, F., Letson, G. D., & Joyce, D. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237111 · Cited by 16

A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma

Tsukamoto, S., Mavrogenis, A. F., Nitta, Y., Righi, A., Masunaga, T., Honoki, K., Fujii, H., Kido, A., Tanaka, Y., Tanaka, Y., et al. (2024) · Current Oncology · doi:10.3390/curroncol31010040 · Cited by 16

Tumor Microenvironment Reprogramming Improves Nanomedicine-Based Chemo-Immunotherapy in Sarcomas

Charalambous, A., Mpekris, F., Panagi, M., Voutouri, C., Michael, C., Gabizón, A., & Stylianopoulos, T. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0772 · Cited by 16

Resource‐appropriate selection of osteosarcoma treatment protocols in low‐ and middle‐income countries

Mailankody, S., Kumar, V. S., Khan, S. A., Banavali, S. D., & Bajpai, J. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29540 · Cited by 16

Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design

Hoppe, B. S., Petersen, I. A., Wilke, B. K., DeWees, T. A., Imai, R., Hug, E. B., Fiore, M. R., Debus, J., Fossati, P., Yamada, S., et al. (2023) · Cancers · doi:10.3390/cancers15061660 · Cited by 16

90 Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors

Lanzafame, H., Heilig, C. E., Wardelmann, E., Desaulniers, M., Pabst, K. M., Mavroeidi, I. A., Pretzell, I., Costa, P. F., Nader, M., Leyser, S., et al. (2025) · Journal of Nuclear Medicine · doi:10.2967/jnumed.125.269572 · Cited by 15

Electrochemotherapy in the Treatment of Bone Metastases: A Systematic Review

Bocchi, M. B., Meschini, C., Pietramala, S., Perna, A., Oliva, M. S., Matrangolo, M. R., Ziranu, A., Maccauro, G., & Vitiello, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196150 · Cited by 15

Fibroblast Activation Protein Inhibitor Theranostics

Hamacher, R., Lanzafame, H., Mavroeidi, I. A., Pabst, K. M., Kessler, L., Cheung, P. F., Bauer, S., Herrmann, K., Schildhaus, H., Siveke, J. T., et al. (2023) · PET Clinics · doi:10.1016/j.cpet.2023.02.008 · Cited by 15

Mutational landscape of primary and recurrent Ewing sarcoma

Jagodzińska-Mucha, P., Sobczuk, P., Mikuła, M., Raciborska, A., Dawidowska, A., Kulecka, M., Bilska, K., Szumera‐Ciećkiewicz, A., Kluska, A., Piątkowska, M., et al. (2021) · Współczesna Onkologia · doi:10.5114/wo.2021.112234 · Cited by 14

Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas

Wood, G. E., Graves, L. A., Rubin, E. M., Reed, D. R., Riedel, R. F., & Strauss, S. J. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_390306 · Cited by 16

Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials

Palmerini, E., Meazza, C., Tamburini, A., Márquez-Vega, C., Bisogno, G., Fagioli, F., Ferraresi, V., Milano, G. M., Coccoli, L., Rubio‐San‐Simón, A., et al. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-25-00210 · Cited by 13

Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapy

Seidensaal, K., Dostal, M., Liermann, J., Adeberg, S., Weykamp, F., Schmid, M. P., Freudlsperger, C., Hoffmann, J., Hompland, I., Herfarth, K. K., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.927399 · Cited by 13

From biology to personalized medicine: Recent knowledge in osteosarcoma

Mohr, A., Costa, M. E. M. D., Fromigué, O., Audinot, B., Balde, T., Droit, R., Abbou, S. D., Khneisser, P., Berlanga, P., Pérez, E., et al. (2024) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2024.104941 · Cited by 13

Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children’s Oncology Group Bone Tumor Committee Consensus Statement

Dietz, M. S., Al‐Ibraheemi, A., Davis, J. L., Hawkins, C. M., Craig, B. T., Dasgupta, R. A., Geller, D. S., Shulman, D. S., Cohen‐Gogo, S., Gupta, A. K., et al. (2024) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2024.7063 · Cited by 13

A narrative review on diagnosis and treatment of ifosfamide-induced encephalopathy, the perspective of a EURACAN reference center for sarcomas

Torchia, A., Vari, S., Onesti, C. E., Ceddia, S., Maschio, M. C. E., Maggi, G., Riva, F., Faltyn, W., Russillo, M., & Ferraresi, V. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1512966 · Cited by 13

Prognostic Factors in Newly Diagnosed High‐Grade Osteosarcoma—A Systematic Review

Tirtei, E., Michelsen, S. W., Haveman, L., Meazza, C., Oliveira, J., Rasool, A., Palmerini, E., Wilson, W., Gaspar, N., Strauss, S. J., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.71044 · Cited by 13

Three-dimensional preclinical models for Osteosarcoma: Advances and translational prospects

Puce, A., Ferraresi, V., Biagini, R., Soddu, S., & Loria, R. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118471 · Cited by 14

The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma

Hu, L., Wu, X., Chen, D., Cao, Z., Li, Z., Liu, Y., & Zhao, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.814722 · Cited by 13

Prostate-specific membrane antigen (PSMA) as a potential target for molecular imaging and treatment in bone and soft tissue sarcomas

Kleiburg, F., Heijmen, L., Gelderblom, H. A. J., Kiełbasa, S. M., Bovée, J. V. M. G., & de Geus‐Oei, L. (2023) · British Journal of Radiology · doi:10.1259/bjr.20220886 · Cited by 14

Chronic health conditions among long‐term survivors of adolescent and young adult cancer: A comparison of outcomes in Israel and the United States

Hayek, S., Libresco, G., Barda, N., Chao, C., Xu, L., Cannavale, K. L., Izraeli, S., & Armenian, S. H. (2023) · Cancer · doi:10.1002/cncr.34740 · Cited by 13

Emerging roles of long non-coding RNAs in osteosarcoma

Liao, X., Wei, R., Zhou, J., Wu, K., & Li, J. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1327459 · Cited by 14

How to Preserve Fertility in Reproductive-Age Women with Cancer

Jaeck, S., Depuydt, C., Bernard, V., Ammar, O. F., Hocké, C., Carrière, J., & Chansel‐Debordeaux, L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14061912 · Cited by 12

Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization

McAloney, C. A., Makkawi, R., Budhathoki, Y., Cannon, M. V., Franz, E., Gross, A. C., Cam, M., Vetter, T. A., Duhen, R., Davies, A. E., et al. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00867-w · Cited by 12

Primary Multi-Systemic Metastases in Osteosarcoma: Presentation, Treatment, and Survival of 83 Patients of the Cooperative Osteosarcoma Study Group

Mettmann, V. L., Blattmann, C., Friedel, G., Harrabi, S., Kalle, T. V., Kager, L., Kevric, M., Kühne, T., Nathrath, M., Sorg, B., et al. (2024) · Cancers · doi:10.3390/cancers16020275 · Cited by 12

Impact of Age at Diagnosis on Cardiotoxicity in High-Grade Osteosarcoma and Ewing Sarcoma Patients

Heemelaar, J. C., Speetjens, F. M., Jaff, A. A. M. A., Evenhuis, R. E., Polomski, E. A. S., Mertens, B. J. A., Jukema, J. W., Gelderblom, H. A. J., van de Sande, M. A. J., & Antoni, M. L. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.11.016 · Cited by 12

Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial

Heesen, P., Ranft, A., Bhadri, V. A., Brichard, B., Collaud, S., Cyprová, S., Eich, H. T., Ek, T., Gelderblom, H. A. J., Hardes, J., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113260 · Cited by 12

Genetic predisposition in sarcomas: clinical implications and management

Connolly, E. A., Boye, K., Bonvalot, S., Kratz, C. P., Leithner, A., Malkin, D. M., Messiou, C., Miah, A. B., Pantziarka, P., Timmermann, B., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103203 · Cited by 11

European Reference Networks – a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025

Graeßner, H., Ripp, S., Pereira, A. M., Schaefer, F. S., Mathijssen, I. M. J., Blay, J., Mulders, P., Evangelista, T., Ligtenberg, M. J. L., Wilde, A. A. M., et al. (2026) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-026-04341-2 · Cited by 11

Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa study

Bonilla, S. A. Z., Fried, M., Singer, S., Hentschel, L., Richter, S., Hohenberger, P., Kasper, B., Andreou, D., Pink, D., Arndt, K., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04556-3 · Cited by 11

Management of elderly patients with bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group

Tanaka, K., & Ozaki, T. (2022) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyac027 · Cited by 11

Extraskeletal Ewing’s sarcoma of the mediastinum: Case report

Caltavituro, A., Buonaiuto, R., Salomone, F., Morra, R. P., Pietroluongo, E., Placido, P. D., Tortora, M., Peddio, A., Picozzi, F., Ottaviano, M., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1074378 · Cited by 11

The prognostic significance of surgical resection margins for local recurrence, distant metastasis, and overall survival in sarcoma

Stauss, R. D., Aigner, A., Richter, A., Suero, E. M., Altemeier, A., Savov, P., Ettinger, M., & Omar, M. (2023) · Journal of Surgical Oncology · doi:10.1002/jso.27411 · Cited by 10

Prolonged 14-day continuous infusion of high-dose ifosfamide for patients with relapsed and refractory high-grade osteosarcoma: a retrospective multicentre cohort study

Tirtei, E., Campello, A., Sciannameo, V., Asaftei, S. D., Meazza, C., Sironi, G., Longhi, A., Ibrahim, T., Tamburini, A., Coccoli, L., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-12498-x · Cited by 10

Automated detection of bone lesions using CT and MRI: a systematic review

Erdem, F., Gitto, S., Fusco, S., Bausano, M. V., Serpi, F., Albano, D., Messina, C., & Sconfienza, L. M. (2024) · La radiologia medica · doi:10.1007/s11547-024-01913-9 · Cited by 10

PET-CT in Clinical Adult Oncology—VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors

Fine, G., Covington, M. F., Koppula, B. R., Salem, A. E., Wiggins, R. H., Hoffman, J. M., & Morton, K. A. (2022) · Cancers · doi:10.3390/cancers14122835 · Cited by 10

Management of Scapular Tumors

Houdek, M. T., Wilke, B. K., & Barlow, J. D. (2022) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2022.08.009 · Cited by 10

Function and return to sports after proximal humeral replacement in patients with primary bone sarcoma

Ellerbrock, M., Theil, C., Gosheger, G., Deventer, N., Klingebiel, S., Rickert, C., & Schneider, K. N. (2022) · Journal of Orthopaedics and Traumatology · doi:10.1186/s10195-022-00678-z · Cited by 10

Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS)

Bielack, S., Kager, L., Kühne, T., ten Langer, T. S., Reichardt, P., Blattmann, C., Kevric, M., Mettmann, V. L., Sorg, B., & Hecker‐Nolting, S. (2023) · Cancers · doi:10.3390/cancers15051520 · Cited by 10

Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience

Berclaz, L. M., Burkhard‐Meier, A., Lange, P., Gioia, D. D., Schmidt, M., Knösel, T., Klauschen, F., von Bergwelt‐Baildon, M., Heinemann, V., Greif, P. A., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05179-y · Cited by 10

Current indications for denosumab in benign bone tumours

Antal, I., Sápi, Z., & Szendrői, M. (2023) · EFORT Open Reviews · doi:10.1530/eor-23-0138 · Cited by 10

What Do We Know about Survival in Skeletally Premature Children Aged 0 to 10 Years with Ewing Sarcoma? A Multicenter 10-Year Follow-Up Study in 60 Patients

Bosma, S. E., van der Heijden, L., Sierrasesúmaga, L., Merks, J. H. M., Haveman, L., van de Sande, M. A. J., & San-Julián, M. (2022) · Cancers · doi:10.3390/cancers14061456 · Cited by 10

Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.

Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy310 · Cited by 617

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2012) · Annals of Oncology · doi:10.1093/annonc/mds254 · Cited by 84

The ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guidelines for bone sarcomas – the challenges of the fight against rare cancers

Andreou, D. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.09.013 · Cited by 3

Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Paulussen, M., Bielack, S., Jürgens, H., & Casali, P. G. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp155 · Cited by 99

Ewing's sarcoma of bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Saeter, G. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm048 · Cited by 11